FINAL Program
friday December 1, 2023
Welcome and Opening Remarks
8:30 am US CST
Venkata Srikanth Garikipati, PhD (USA)
KeyNote Presentation
Maria Kontaridis, PHD
Masonic Medical Research Institute, USA
8:40 am US CST
Myeloid-specific Regulation of RhoA in Cardiac Fibrosis
Session 6 : Cardiac immunology & cell-cell communication
Moderators
Weijia Luo, PhD
Texas A&M University, USA
Rongxue "Rosie" Wu, MD, PhD
University of Chicago, USA
Rajesh Katare, MD, PHD
University of Otago, New Zealand
09:00 am US CST
Diagnostic and prognostic role of circulating microRNAs
Leah Cahill, phd
Dalhousie University, Canada
09:15 am US CST
The haptoglobin phenotype biomarker and risk of cardiovascular disease in people with type 2 diabetes
Sarah Dick, PHD
Queen's University, Canada
09:30 am US CST
Tissue Resident Macrophages as Modulators of Cardiac Repair
MuruGesan Rajaram, PHD
The Ohio State University, USA
09:45 am US CST
Role of Macrophages on cardiac dysfunction during lethal Pneumonia
Fabio Recchia, md, phd
Institute of Clinical Physiology Pisa, Italy
10:00 am US CST
microRNAs Delivery to Repair the Infarcted Heart
Break
KeyNote Presentation
Thomas Hund, PHD
The Ohio State University, USA
10:25 am US CST
Novel role of the spectrin cytoskeleton in tuning cardiac remodeling
Session 7: Metabolic cardiovascular disease
Moderators
Thomas Pulinilkunnil, PhD
Dalhousie University, Canada
Wing-Tak Jack Wong, PhD
Chinese University of Hong Kong
Lisa Heather, PHD
University of Oxford, UK
10:45 am US CST
Metabolic control of hypoxic signalling as a therapeutic target in diabetes
Sihem Boudina, PHD
University of Utah, USA
11:00 am US CST
Cardiac metabolism in congenital cardiomyopathies
brian Rodrigues, bsc, PHD
University of British Columbia, Canada
11:15 am US CST
Fatty acid delivery to the heart and changes following diabetes
Rushita Bagchi, PHD
University of Arkansas for Medical Sciences, USA
11:30 am US CST
Targeting fatty acylation in cardiometabolic disease
Break
KeyNote Presentation
Michael Czubryt, PhD, FCVS, FAHA, FIACS
University of Manitoba, Canada
12:15 pm US CST
Targeting Fibroblast Activation to Treat Cardiac Fibrosis
Session 8 : Cardiovascular fibrosis & hemodynamics
Moderators
Sadia Mohsin, PhD
Temple University, USA
Dhanendra Tomar, PhD
Wake Forest University, USA
Ian Dixon, phd
University of Manitoba, Canada
12:35 pm US CST
Scleraxis and SKI as modulators of fibroblast phenotype
Vidu Garg, MD
The Ohio State University, USA
12:50 pm US CST
Notch signaling & bicuspid aortic valve disease
Liya Yin, MD, PhD, FCVS, FAHA
Northeast Ohio Medical University, USA
01:05 pm US CST
Regulation of Coronary Microcirculation in Metabolic Syndrome
Keith Brunt, PHD
Dalhousie University, Canada
01:20 pm US CST
Re-establishing heme homeostasis for cardiac hemodynamic stability to arrest heart failure progression
Break
KeyNote Presentation
Na Li, phd
Baylor College of Medicine, USA
01:45 pm US CST
Inflammasome signaling and atrial arrhythmogenesis
Session 9 : Cardiac arrhythmia & ion homeostasis
Moderators
Venkata Srikanth Garikipati, PhD
Temple University, USA
Suresh K Verma, PhD
University of Alabama at Birmingham, USA
Michel EspinoZa-Fonseca, phd
University of Michigan, USA
02:05 pm US CST
Design of small-molecule effectors targeting the calcium pumps in the heart
Céline Fiset, bpharm, phd
Université de Montréal, Canada
02:20 pm US CST
Mechanisms underlying sex differences in atrial fibrillation
Charles Thodeti, PhD, FAHA, FCVS
University of Toledo, USA
02:35 pm US CST
Endothelial Mechanotransduction in Cardiac Remodeling
HarpReet Singh, phd
The Ohio State University, USA
02:50 pm US CST